Immunoprecise Antibodies Stock Technical Analysis

IPA Stock  USD 1.22  0.03  2.40%   
As of the 24th of April, Immunoprecise Antibodies retains the Standard Deviation of 5.83, market risk adjusted performance of (0.05), and Risk Adjusted Performance of 9.0E-4. Immunoprecise Antibodies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Immunoprecise Antibodies, which can be compared to its competitors. Please check out Immunoprecise Antibodies variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Immunoprecise Antibodies is priced fairly, providing market reflects its last-minute price of 1.22 per share. Given that Immunoprecise Antibodies is a hitting penny stock territory we urge to closely look at its jensen alpha.

Immunoprecise Antibodies Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immunoprecise, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Immunoprecise
  
Immunoprecise Antibodies' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Immunoprecise Antibodies Analyst Consensus

Target PriceAdvice# of Analysts
7.99Strong Buy2Odds
Immunoprecise Antibodies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Immunoprecise analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunoprecise stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunoprecise Antibodies, talking to its executives and customers, or listening to Immunoprecise conference calls.
Immunoprecise Analyst Advice Details
Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunoprecise Antibodies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunoprecise Antibodies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Immunoprecise Antibodies Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Immunoprecise Antibodies volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Immunoprecise Antibodies Trend Analysis

Use this graph to draw trend lines for Immunoprecise Antibodies. You can use it to identify possible trend reversals for Immunoprecise Antibodies as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Immunoprecise Antibodies price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Immunoprecise Antibodies Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Immunoprecise Antibodies applied against its price change over selected period. The best fit line has a slop of   0.01  , which may imply that the returns on investment in Immunoprecise Antibodies will continue to fail. It has 122 observation points and a regression sum of squares at 7.48, which is the sum of squared deviations for the predicted Immunoprecise Antibodies price change compared to its average price change.

About Immunoprecise Antibodies Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunoprecise Antibodies on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunoprecise Antibodies based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunoprecise Antibodies price pattern first instead of the macroeconomic environment surrounding Immunoprecise Antibodies. By analyzing Immunoprecise Antibodies's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunoprecise Antibodies's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunoprecise Antibodies specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.0045260.004299
Price To Sales Ratio111.0189.68

Immunoprecise Antibodies April 24, 2024 Technical Indicators

Most technical analysis of Immunoprecise help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunoprecise from various momentum indicators to cycle indicators. When you analyze Immunoprecise charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Immunoprecise Antibodies April 24, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immunoprecise stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Immunoprecise Antibodies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunoprecise Antibodies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunoprecise Antibodies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunoprecise Antibodies Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunoprecise Antibodies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.47)
Revenue Per Share
0.939
Quarterly Revenue Growth
0.203
Return On Assets
(0.11)
Return On Equity
(0.26)
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunoprecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.